Literature DB >> 11136193

Drug-induced acute interstitial nephritis and vasculitis or vasculary rejection in renal allografts.

S Sen1, R Bayrak, E Ok, G Başdemir.   

Abstract

We describe a patient who sought treatment for acute renal allograft dysfunction 2 weeks after renal transplantation. Renal allograft biopsy (RAB) showed intimal arteritis, severe interstitial infiltration with a few eosinophils, and severe tubulitis. Pathologic diagnosis was acute rejection (grade 2b- Banff 93); however, another clinical diagnosis, drug-induced acute interstitial nephritis (AIN), was not excluded. Before the RAB, his trimethaprim-sulfamethoxazole (TMP-SMZ) treatment was discontinued. Renal function began to improve on biopsy day without antirejection therapy. Recovery of renal function without antirejection treatment and discontinuation of TMP-SMZ shows that renal pathology might be related to drug-induced dysfunction and drug-induced AIN and vasculitis. After 5 years, the patient and his renal allograft function are both well.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136193

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Lansoprazole-induced acute allergic interstitial nephritis in a renal transplant recipient: a case report.

Authors:  Tolga Yildirim; Rahmi Yilmaz; Dilek Ertoy Baydar; Aysun Aybal Kutlugun; Tuncay Aki; Cetin Turgan
Journal:  Int Urol Nephrol       Date:  2011-05-03       Impact factor: 2.370

2.  Lower risk of urinary tract infection with low-dose trimethoprim/sulfamethoxazole compared to dapsone prophylaxis in older renal transplant patients on a rapid steroid-withdrawal immunosuppression regimen.

Authors:  Jeffrey Allen Giullian; Kerri Cavanaugh; Heidi Schaefer
Journal:  Clin Transplant       Date:  2010 Sep-Oct       Impact factor: 2.863

3.  ADAMTS13 deficiency and thrombotic thrombocytopenic purpura associated with trimethoprim-sulfamethoxazole.

Authors:  Sowjanya Bapani; Narendranath Epperla; Yusuf Kasirye; Richard Mercier; Romel Garcia-Montilla
Journal:  Clin Med Res       Date:  2012-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.